HemaSphere (Nov 2022)

High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis

  • Elsemieke te Linde,
  • Laura J. E. Boots,
  • Laura G. M. Daenen,
  • Moniek A. de Witte,
  • Anke H. W. Bruns

DOI
https://doi.org/10.1097/HS9.0000000000000793
Journal volume & issue
Vol. 6, no. 11
p. e793

Abstract

Read online

No abstracts available.